Shriners Hospitals for Children, Los Angeles, USA.
Spine (Phila Pa 1976). 2010 Jan 15;35(2):246-51. doi: 10.1097/BRS.0b013e3181bdf22a.
Retrospective case-control study.
Determine whether intraoperative cell salvage system use during pediatric posterior spinal fusion (PSF) with segmental spinal instrumentation for idiopathic scoliosis decreases intraoperative and perioperative (intraoperative plus postoperative) allogeneic blood transfusion.
Intraoperative cell salvage and reinfusion can reduce or obviate perioperative allogeneic blood transfusion. Despite these benefits, their efficacy in pediatric PSF is unclear. Reported complications include transient hematuria, altered hemostasis, and electrolyte imbalance.
A total of 54 consecutive idiopathic scoliosis patients were studied: 21 non-cell saver and 33 cell saver patients. Data included age, body mass index, Cobb angle, perioperative hemoglobin levels, mean arterial pressure, surgical time, levels fused, perioperative estimated blood loss, and perioperative transfusions. A chi2 and t tests were performed for intraoperative and perioperative allogeneic transfusion between groups. A regression analysis was performed between selected covariates and allogeneic transfusion. Relative risk analysis examined significant covariates regarding allogeneic transfusion rate.
Allogeneic transfusion rates were lower in the cell saver group (6% vs. 55% intraoperative and 18% vs. 55% perioperative, P < 0.05). Mean allogeneic transfusion volumes (mL/kg) were also lower (0.4 vs. 9.1 intraoperative and 1.9 vs. 11.1 perioperative, P < 0.05). Multivariate analysis confirmed these differences were independent of perioperative blood loss, and also demonstrated that surgical time and blood loss were significantly related to allogeneic transfusion volume. The allogeneic transfusion relative risk was 2.04 in patients with surgery >6 hours and 5.87 in patients not receiving cell saver blood. All patients with surgeries >6 hours and estimated blood loss >30% of total blood volume received cell saver system blood.
Cell saver use decreased allogeneic transfusion, particularly in surgeries >6 hours with estimated blood loss >30% of total blood volume. This study confirms the utility of routine cell saver use during PSF with segmental spinal instrumentation for idiopathic scoliosis.
回顾性病例对照研究。
确定在儿童后路脊柱融合术(PSF)中使用术中细胞回收系统是否会减少节段性脊柱器械固定特发性脊柱侧凸的术中及围术期(术中加术后)异体输血。
术中细胞回收和再输注可减少或避免围术期异体输血。尽管有这些益处,但它们在儿童 PSF 中的疗效尚不清楚。据报道,并发症包括短暂性血尿、止血改变和电解质失衡。
对 54 例特发性脊柱侧凸患者进行了研究:21 例非细胞回收组和 33 例细胞回收组。数据包括年龄、体重指数、Cobb 角、围术期血红蛋白水平、平均动脉压、手术时间、融合节段数、围术期估计失血量和围术期输血。对两组间术中及围术期异体输血进行卡方检验和 t 检验。对异体输血与选定协变量之间进行回归分析。对异体输血率的显著协变量进行相对风险分析。
细胞回收组异体输血率较低(术中 6%比 55%,围术期 18%比 55%,P < 0.05)。异体输血量(mL/kg)也较低(术中 0.4 比 9.1,围术期 1.9 比 11.1,P < 0.05)。多变量分析证实这些差异与围术期失血量无关,还表明手术时间和失血量与异体输血量显著相关。手术时间 >6 小时和未接受细胞回收的患者异体输血的相对风险分别为 2.04 和 5.87。所有手术时间 >6 小时且估计失血量 >总血容量 30%的患者均接受了细胞回收系统的血液。
细胞回收的使用减少了异体输血,特别是在手术时间 >6 小时且估计失血量 >总血容量 30%的情况下。本研究证实了在特发性脊柱侧凸节段性脊柱器械固定的 PSF 中常规使用细胞回收的有效性。